Qube Research & Technologies LTD Procept Bio Robotics Corp Transaction History
Qube Research & Technologies LTD
- $65.7 Billion
- Q3 2024
A detailed history of Qube Research & Technologies LTD transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Qube Research & Technologies LTD holds 28,192 shares of PRCT stock, worth $2.64 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,192
Previous 36,051
21.8%
Holding current value
$2.64 Million
Previous $2.2 Million
2.54%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding PRCT
# of Institutions
266Shares Held
38MCall Options Held
262KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA4.84MShares$453 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$326 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.53MShares$144 Million0.04% of portfolio
-
Loomis Sayles & CO L P1.24MShares$116 Million0.13% of portfolio
-
State Street Corp Boston, MA1.18MShares$110 Million0.0% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $4.17B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...